09:14 AM EDT, 06/15/2026 (MT Newswires) -- Healthcare stocks were edging higher premarket Monday, with the State Street Health Care Select Sector SPDR ETF ( XLV ) up 0.2% and the iShares Biotechnology ETF (IBB) 0.6% higher.

Precigen ( PGEN ) shares were up more than 3% after the company said the US Food and Drug Administration granted orphan drug exclusivity for its recurrent respiratory papillomatosis treatment called papzimeos.

Zymeworks' ( ZYME ) drug to treat certain reproductive tract cancers has shown promise in early testing, the biotechnology company reported at the European Society for Medical Oncology Gynaecological Cancers Congress. Zymeworks ( ZYME ) stock was up more than 1% pre-bell.

Elicio Therapeutics ( ELTX ) shares were down more than 64% after the company said its Phase 2 clinical study evaluating the experimental pancreatic cancer therapy ELI-002 7p did not meet the pre-specified primary endpoint of disease-free survival.